首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Influence of glycosylation on the clearance of recombinant human sex hormone-binding globulin from rabbit blood
Authors:Cousin P  Déchaud H  Grenot C  Lejeune H  Hammond G L  Pugeat M
Institution:

a Laboratoire de la Clinique Endocrinologique, Hôpital de l'Antiquaille, 1 rue de l'Antiquaille, 69321 Lyon Cedex 05, France

b Laboratoire Central de Biochimie, Hôpital de l'Antiquaille, 1 rue de l'Antiquaille, 69321 Lyon Cedex 05, France

c INSERM U 329, Hôpital Debrousse, rue Sœur Bouvier, 69005 Lyon, France

d Department of Obstetrics and Gynecology, University of Western Ontario, London Regional Cancer Centre, London, Ont. N6A 4L6, Canada

e Department of Pharmacology and Toxicology, University of Western Ontario, London Regional Cancer Centre, London, Ont. N6A 4L6, Canada

Abstract:Human sex hormone-binding globulin (hSHBG) is a plasma glycoprotein that binds sex steroids with high affinity. Variations in hSHBG glycosylation contribute to its electrophoretic microheterogeneity, but the functional significance of different SHBG glycoforms is unknown. Carbohydrates may influence the biological activities and half-lives of glycoproteins and we have examined how oligosaccharides at specific sites influence the plasma clearance of hSHBG in vivo. To accomplish this, fully-glycosylated hSHBG, or hSHBG mutants lacking specific oligosaccharides chains, were expressed in Chinese hamster ovary (CHO) cells and purified by immunoaffinity chromatography. The purified recombinant proteins were then biotinylated to study their plasma half-lives after intravenous injection into rabbits. When compared to hSHBG isolated from serum, recombinant hSHBG migrates with a slightly larger average molecular size during denaturing polyacrylamide gel electrophoresis. This is due to a greater proportion (33–39% vs. 3%) of more highly branched N-linked oligosaccharides on the recombinant proteins. When injected into rabbits, the disappearance of recombinant hSHBG showed two exponential components, as previously shown for natural hSHBG in the same animal model. The mean±S.E.M. plasma half-lives of recombinant hSHBG (t1/2greek small letter alpha 0.11±0.03 h and t1/2β 18.94±1.65 h) are shorter than previously measured for natural hSHBG (t1/2greek small letter alpha 3.43±0.72 h and t1/2β 38.18±7.22 h) and this is likely due to differences in the composition of their N-linked oligosaccharides. An O-linked chain at Thr7 does not influence the plasma clearance of hSHBG in the presence or absence of N-linked carbohydrates at Asn351 and Asn367. However, a 1.5–1.6 fold (p<0.03) increase in plasma half-life of variants lacking both N-glycosylation sites was observed and this is probably due to the fact these variants are not recognized by the asialoglycoprotein receptor-mediated clearance system. Removal of either N-glycosylation consensus site also increased (p<0.0001) the plasma half-life of hSHBG by 2.3–2.4 fold. Thus, the metabolic clearance of hSHBG appears to be determined by the number of N-linked oligosaccharides rather than their location.
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号